385 related articles for article (PubMed ID: 34007003)
21. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
22. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
[TBL] [Abstract][Full Text] [Related]
23. LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway.
Zhang H; Pan YZ; Cheung M; Cao M; Yu C; Chen L; Zhan L; He ZW; Sun CY
Cell Death Dis; 2019 Mar; 10(3):230. PubMed ID: 30850586
[TBL] [Abstract][Full Text] [Related]
24. Laminin‑332 mediates proliferation, apoptosis, invasion, migration and epithelial‑to‑mesenchymal transition in pancreatic ductal adenocarcinoma.
Huang C; Chen J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179081
[TBL] [Abstract][Full Text] [Related]
25. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
Li Y; Su Z; Wei B; Qin M; Liang Z
Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
[TBL] [Abstract][Full Text] [Related]
27. Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis.
Wu J; Li Z; Zeng K; Wu K; Xu D; Zhou J; Xu L
Mol Med Rep; 2019 Aug; 20(2):1343-1352. PubMed ID: 31173193
[TBL] [Abstract][Full Text] [Related]
28. Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma.
Okada Y; Nishiwada S; Yamamura K; Sho M; Baba H; Takayama T; Goel A
Eur J Cancer; 2021 Mar; 146():125-134. PubMed ID: 33607476
[TBL] [Abstract][Full Text] [Related]
29. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.
Zhao L; Zhao H; Yan H
BMC Cancer; 2018 May; 18(1):603. PubMed ID: 29843660
[TBL] [Abstract][Full Text] [Related]
31. Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets.
Ma Y; Pu Y; Peng L; Luo X; Xu J; Peng Y; Tang X
Oncol Lett; 2019 Dec; 18(6):6741-6751. PubMed ID: 31807183
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
[TBL] [Abstract][Full Text] [Related]
33. LAMC2 promotes cancer progression and gemcitabine resistance through modulation of EMT and ATP-binding cassette transporters in pancreatic ductal adenocarcinoma.
Okada Y; Takahashi N; Takayama T; Goel A
Carcinogenesis; 2021 Apr; 42(4):546-556. PubMed ID: 33624791
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of the LAMB3 and LAMC2 genes between small cell and non-small cell lung carcinomas.
Manda R; Kohno T; Niki T; Yamada T; Takenoshita S; Kuwano H; Yokota J
Biochem Biophys Res Commun; 2000 Aug; 275(2):440-5. PubMed ID: 10964684
[TBL] [Abstract][Full Text] [Related]
35. Silencing of LAMC2 Reverses Epithelial Mesenchymal Transition and Inhibits Progression in Pancreatic Ductal Adenocarcinoma via Inactivation of the NF-κB Signaling Pathway.
Huang L; Han Y; Zhou Q; Sun Z; Yan J
Crit Rev Eukaryot Gene Expr; 2023; 33(4):13-23. PubMed ID: 37183943
[TBL] [Abstract][Full Text] [Related]
36. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma.
Hao S; Yao L; Huang J; He H; Yang F; Di Y; Jin C; Fu D
Technol Cancer Res Treat; 2018 Jan; 17():1533034617748429. PubMed ID: 29343207
[TBL] [Abstract][Full Text] [Related]
37. S100A10 Promotes Pancreatic Ductal Adenocarcinoma Cells Proliferation, Migration and Adhesion through JNK/LAMB3-LAMC2 Axis.
Lin H; Yang P; Li B; Chang Y; Chen Y; Li Y; Liu K; Liang X; Chen T; Dai Y; Pang W; Zeng L
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612197
[TBL] [Abstract][Full Text] [Related]
38. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data.
Li N; Zhao X; You S
Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213
[TBL] [Abstract][Full Text] [Related]
39. Identification of Core Prognosis-Related Candidate Genes in Chinese Gastric Cancer Population Based on Integrated Bioinformatics.
Li M; Wang X; Liu J; Mao X; Li D; Wang Z; Tang Y; Wu S
Biomed Res Int; 2020; 2020():8859826. PubMed ID: 33381592
[TBL] [Abstract][Full Text] [Related]
40. Is Integrin Subunit Alpha 2 Expression a Prognostic Factor for Liver Carcinoma? A Validation Experiment Based on Bioinformatics Analysis.
Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Luo Y; Zhu Y
Pathol Oncol Res; 2019 Oct; 25(4):1545-1552. PubMed ID: 30515639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]